AEVS
Aevis Victoria SA insider transactions
Healthcare · SIX · Switzerland
Net insider signal · last quarter
Neutral
Share price & insider trades · last quarter ▲ buy ▼ sell
CHF 14.1 CHF 12.0 10 Apr 09 Jul
Insiders were net buyers over the last quarter — 1 buy against 1 sell — a net CHF 0 of buying. Most recent filing: 10 Jun 2026.
Net insider flow · last quarter
+CHF 0 1 buys · 1 sells
Insider profiles
+●.●% avg 3m · win rate
Transactions
10 Jun 2026 Management Sell CHF 4,029,000 10 Jun 2026 Management Buy CHF 4,029,000 18 Mar 2026 Management Buy CHF 25,005
08 Mar 2026 Management ▲ Buy CHF 20,996
05 Feb 2026 Management ▼ Sell CHF 10,464,000
05 Feb 2026 Management ▲ Buy CHF 10,464,000
03 Feb 2026 Management ▼ Sell CHF 2,616,000
03 Feb 2026 Management ▲ Buy CHF 2,616,000
29 Dec 2025 Management ▼ Sell CHF 1,360,000
16 Dec 2025 Management ▼ Sell CHF 2,600,000
07 Oct 2025 Management ▼ Sell CHF 3,250,000
03 Oct 2025 Management ▼ Sell CHF 260,000
01 Oct 2025 Management ▼ Sell CHF 3,836,000
11 Sep 2025 Management ▼ Sell CHF 397,500
15 Aug 2025 Management ▲ Buy CHF 214,400
24 Jul 2025 Management ▼ Sell CHF 455,000
15 Jul 2025 Management ▼ Sell CHF 1,508,000
14 Jul 2025 Management ▼ Sell CHF 1,293,500
02 Jun 2025 Management ▼ Sell CHF 3,305,000
02 Jun 2025 Management ▲ Buy CHF 3,305,000
30 May 2025 Management ▼ Sell CHF 405,000
21 May 2025 Management ▼ Sell CHF 1,315,000
31 Mar 2025 Management ▲ Buy CHF 3,382,500
31 Mar 2025 Management ▼ Sell CHF 3,382,500
24 Mar 2025 Management ▲ Buy CHF 24,882
Showing older filings · the 3 most recent are subscriber-only
Under the EU Market Abuse Regulation (MAR), executives and board members (PDMRs) at Swiss-listed companies must disclose dealings in their company's shares to SIX. Insider Transaction Terminal aggregates these filings daily, filters out the noise and gives you the trades that actually matter.